45 results on '"Baldari S."'
Search Results
2. P15.13.B Role and accuracy of FET-PET in gliomas, and its significance in the differential diagnosis among progression, pseudoprogression, and response to treatments
3. 1394P Alkaline phosphatase (ALP) decline and pain response as markers for overall survival (OS) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (223Ra) in the REASSURE study
4. Internal dosimetry Monte Carlo study of TARE treatments: a comparison between GATE and GAMOS focused on lung dosimetry and background correction
5. Molecular imaging of pancreatic neoplasms
6. PCN168 Lutetium (177LU) Oxodotreotide Versus Standard of Care in Adult Patients with Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): A Cost-Consequences Analysis from an Italian Hospital Perspective
7. Letter to the editor regarding “Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw”
8. Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
9. PET/MR in neuro-oncology: is it ready for prime-time?
10. Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation
11. Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience
12. 313. Estimation of the radiation absorbed dose to the choroid plexuses in 68Ga-NODAGA-RGD PET
13. 93. Estimation of doses to the extremities during manipulation of radiopharmaceuticals in nuclear medicine: A Monte Carlo calculation approach in realistic geometric lay-outs
14. Comment on: Lack of association between obesity and aggressiveness of differentiated thyroid cancer
15. Use of bone health agents (BHAs) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) after abiraterone (Abi): An interim review of REASSURE
16. Tumour growth rate (TGR) when using lanreotide Autogel® (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs)
17. Combined BRAFV600E analysis and 99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation
18. REASSURE observational study of radium-223 (Ra-223): First interim results by prior/concomitant treatment (Tx) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) enrolled in Europe
19. Multicentre clinical evaluation of the new highly sensitive Elecsys® thyroglobulin II assay in patients with differentiated thyroid carcinoma
20. Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)
21. Patient (pt) characteristics and treatment patterns in the radium (Ra)-223 REASSURE observational study
22. Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)
23. Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy
24. Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP)
25. Future laser-accelerated proton beams at ELI-Beamlines as potential source of positron emitters for PET
26. BRAF (V600E) mutation in isthmic malignant thyroid nodules
27. Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications
28. P17.13 * ABSCESUALIZED GLIOMAS: PREDICTIVE VALUE OF 99MTC-LEUKOSCAN
29. Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist
30. CKD LAB METHODS, PROGRESSION & RISK FACTORS 1
31. A potentially misleading finding at somatostatin receptor scintigraphy: Focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions
32. The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation
33. First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment
34. Association of Autonomously Functioning Thyroid Nodules with Hashimoto's Thyroiditis: Study on A Large Series of Patients
35. 1408 POSTER DISCUSSION The Role of 2deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography and Maximum Standardized Uptake Value in Predicting Prognosis of Patients With Non-Small Cell Lung Cancer in Different Stages (l-IV)
36. Absorbed fractions for electrons in ellipsoidal volumes
37. Absorbed fractions for photons in ellipsoidal volumes
38. Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormonesecreting adrenal phaeochromocytoma: review of the literature and report of a case
39. Absorbed fractions in ellipsoidal volumes for β−radionuclides employed in internal radiotherapy
40. Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormonesecreting adrenal phaeochromocytoma: review of the literature and report of a case
41. Patent Omphalomesenteric Duct Demonstrated by Intestinal Transit Scintigraphy
42. Evaluation of Chromogranin A Expression in Patients with Non-Neuroendocrine Tumours
43. Use of sulesomab in the diagnosis of brucellar spondylitis
44. Retrospective analysis of the association of nodular goiter with primary and secondary hyperparathyroidism
45. Conservative Treatment in Primary Neonatal Megaureter
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.